## Objective Ecstasy users report a number of complaints after its use including disturbed sleep. However, little is known regarding which attributes of ecstasy use are associated with sleep disturbances, which domains of sleep are affected or which factors may predict those ecstasy users likely to
Self reported sleep quality and cognitive performance in ecstasy users
β Scribed by Catharine Montgomery; John E. Fisk; Michelle Wareing; Philip Murphy
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 139 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.879
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives
Research suggests that ecstasy users exhibit psychobiological changes relative to nonusers such as altered sleep patterns and cognitive deficits. In turn, it has been suggested that sleep quality may be a mediator of such cognitive deficits in ecstasy users. The present study sought to investigate this proposed relationship.
Methods
Aspects of cognitive functioning in 104 ecstasy users and 103 nonusers obtained from our previous studies were reanalysed to explore the extent to which ecstasyβrelated group differences were attributable to differences in sleep quality. Cognitive function was assessed via the computation span test, consonant updating, paired associate learning, syllogistic reasoning and word fluency. Sleep quality was measured via the Epworth Sleepiness Scale (ESS), and the Karolinska Sleepiness Scale (KSS).
Results
Ecstasy users performed worse than nonusers on all cognitive measures. While no differences were observed on the ESS, ecstasy users reported greater tiredness at the beginning of testing than nonusers. When the sleep variables were included as covariates, the effects of ecstasy on all cognitive measures remained significant.
Conclusions
The results of the present study suggest little evidence for the mediating effects of sleep on cognitive function in ecstasy users. Copyright Β© 2007 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
Twenty recreational drug users were asked to describe the psychological and physiological eects they experienced under MDMA (3,4-methylenedioxymethamphetamine). The subjects comprised 11 males and nine females, in the age range 18Β±31 years. Five subjects had taken MDMA once, nine had taken it 2Β±9 ti
## Abstract A 38βyearβold man developed parkinsonism that progressed to Hoehn and Yahr stage 5 within 4 years of onset. Response to ropinirole deteriorated, levodopa was not tolerated, and subthalamic nucleus stimulation has provided only partial relief of symptoms. He reported heavy use of Ecstasy